BRIEF published on 08/22/2024 at 18:05, 1 year 5 months ago ABIONYX Pharma : Bilan du 1er semestre 2024 Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
BRIEF published on 08/22/2024 at 18:05, 1 year 5 months ago ABIONYX Pharma: Review of the first half of 2024 Biotechnology Fundraising Treasury Turnover ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 year 5 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma publie sa position de trésorerie du 1er semestre 2024 avec un chiffre d’affaires consolidé de 2,4 M€. Levée de fonds de 3,4 M€ pour renforcer la trésorerie Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 year 5 months ago Inside Information / Other news releases ABIONYX Pharma reports €2.4m sales and €5.3m cash position for H1 2024, focused on innovative therapies. Raised €3.4m for sepsis program in the US Sales Cash Position Innovative Therapies ABIONYX Pharma Sepsis
BRIEF published on 07/01/2024 at 09:27, 1 year 7 months ago ABIONYX Successfully Completes €3.4 Million Capital Increase Capital Increase Biotech Shares And Warrants ABIONYX Sepsis Development
BRIEF published on 07/01/2024 at 09:27, 1 year 7 months ago ABIONYX finalise avec succès une augmentation de capital de 3,4 millions d'euros Augmentation De Capital Actions Et Bons De Souscription Biotechnologies ABIONYX Développement De La Septicémie
PRESS RELEASE published on 07/01/2024 at 09:22, 1 year 7 months ago Inside Information / Other news releases ABIONYX successfully completes a capital increase of c.€3.4 million through the issuance of shares with warrants. The fundraising aims to strengthen the company's cash position for its development in sepsis and the United States Fundraising Capital Increase Sepsis ABIONYX Shares With Warrants
BRIEF published on 06/27/2024 at 19:27, 1 year 7 months ago ABIONYX Pharma Achieves Unanimous Approval at Combined General Meeting Shareholders Biotech General Meeting Resolutions ABIONYX Pharma
BRIEF published on 06/27/2024 at 19:27, 1 year 7 months ago ABIONYX Pharma obtient l'approbation unanime de l'Assemblée Générale Mixte Actionnaires Assemblée Générale Resolutions Biotechnologies ABIONYX Pharma
PRESS RELEASE published on 06/27/2024 at 19:22, 1 year 7 months ago Inside Information / Other news releases ABIONYX Pharma announces unanimous approval of all resolutions at its Combined General Meeting. Shareholders renew mandates and approve buyback program Shareholders Buyback Program Renewal Combined General Meeting ABIONYX Pharma
Published on 02/10/2026 at 01:05, 5 hours 51 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 02/09/2026 at 23:35, 7 hours 21 minutes ago Mako Mining Announces Intention to Restructure the Mt. Hamilton Acquisition Consideration and Postponement of Special Meeting of Shareholders to New Meeting Date of March 3, 2026
Published on 02/09/2026 at 23:15, 7 hours 41 minutes ago IBC Advanced Alloys to Present at the Precious Metals & Critical Minerals Virtual Investor Conference on February 10, 2026
Published on 02/09/2026 at 23:08, 7 hours 48 minutes ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 02/09/2026 at 23:00, 7 hours 56 minutes ago RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio
Published on 02/10/2026 at 05:00, 1 hour 56 minutes ago Guinness Malaysia reimagines Premier League matchdays with a football-themed stay built for watching matches after midnight
Published on 02/09/2026 at 19:59, 10 hours 56 minutes ago EQS-Adhoc: BOOSTER Precision Components Holding GmbH is not pursuing its planned bond issue and will initiate a written procedure to amend the bonds terms of its existing bond 2022/26
Published on 02/09/2026 at 19:00, 11 hours 56 minutes ago Atlassian Williams F1 Team toasts new partnership with Estrella Galicia 0,0
Published on 02/09/2026 at 19:00, 11 hours 56 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 02 FEVRIER 2026 au 06 FEVRIER 2026
Published on 02/09/2026 at 18:00, 12 hours 56 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 13 hours 11 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 13 hours 11 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 13 hours 11 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 13 hours 11 minutes ago Déclaration des droits de vote à fin janvier 2026
